Clinical Trials Browser

Has results × Endometrial Neoplasms × durvalumab × Clear all

NCT04269200 2025-12-23

DUO-E

Phase 3 Active not recruiting

805 enrolled 18 charts 1 FDA

Endometrial Neoplasms

NCT03015129 2024-02-06

A Study of Durvalumab With or Without Tremelimumab in Endometrial Cancer

Phase 2 Completed

80 enrolled 9 charts

Recurrence, Endometrial Neoplasms